Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05729425 · ClinicalTrials.gov registry record
Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 1
- Enrollment target
NCT05729425: Clinical Trial study, sponsored by Mayo Clinic.
NCT05729425 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05729425 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This study evaluates the accuracy of a new ultrasound technology called microvessel imaging for detecting the extent of disease among patients with angiosarcoma of the skin. Microvessel ultrasound imaging uses high frequency waves to visualize vessels in the skin that are not easily seen using other imaging tests.
Primary Outcome
Accuracy with respect to gold standard quantitative measures of disease extent and imaging-based measurements will be evaluated using Lin's concordance correlation coefficient along with 95% confidence intervals (CI's). These will be performed separately pre- and post-treatment. Pearson correlations and 95% CI's between imaging modality measurements will also be estimated to help guide future comparative analyses. Bland-Altman plots will also be generated to visualize agreement.
Interventions
- DEVICE Ultrasound Microvessel Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-10-31 |
| Est. Completion | 2023-08-15 |
Why NCT05729425 stopped before completion
NCT05729425 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound Microvessel Imaging is the first listed.
NCT05729425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05729425 about?
NCT05729425 is a clinical study titled "Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin". This study evaluates the accuracy of a new ultrasound technology called microvessel imaging for detecting the extent of disease among patients with angiosarcoma of the skin. Microvessel ultrasound imaging uses high frequency waves to visualize vessels in the skin that are not easily seen using other...
What is the current status of trial NCT05729425?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2022-10-31. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05729425?
The interventions under investigation include: Ultrasound Microvessel Imaging (DEVICE).
Who is sponsoring clinical trial NCT05729425?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI